4.9200
+0.4200
+(9.33%)
At close: January 31 at 4:00:01 PM EST
4.9100
-0.01
(-0.20%)
After hours: January 31 at 6:13:37 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 8,563 | 1 |
Sales | 521,160 | 10 |
Net Shares Purchased (Sold) | -512,597 | 11 |
Total Insider Shares Held | 1.26M | -- |
% Net Shares Purchased (Sold) | -28.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
FABBIO PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
SHEFFERMAN JESSE M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
ZUMMO JACQUELINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
FRY HANNAH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.71 per share. | Indirect | 271,715 | Sep 12, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.77 - 1.89 per share. | Indirect | 114,251 | Sep 10, 2024 |
SHEFFERMAN JESSE M Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 28, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.44 per share. | Indirect | 27,828 | Jul 16, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.21 - 2.40 per share. | Indirect | 175,842 | Jul 11, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.12 per share. | Indirect | 17,598 | Jul 1, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.07 - 2.26 per share. | Indirect | 142,503 | Jun 28, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.26 per share. | Indirect | 28,734 | Jun 25, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.90 - 2.94 per share. | Indirect | 44,008 | May 31, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.00 - 3.06 per share. | Indirect | 130,434 | May 22, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.06 - 3.33 per share. | Indirect | 230,326 | May 17, 2024 |
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.09 - 3.11 per share. | Indirect | 566,951 | May 10, 2024 |
FABBIO PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
SHEFFERMAN JESSE M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
ZUMMO JACQUELINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
BANDARI JATHIN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
FRY HANNAH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
SHEFFERMAN JESSE M Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
Related Tickers
RZLT Rezolute, Inc.
5.25
+0.77%
GRCE Grace Therapeutics, Inc.
3.3000
+2.80%
SLDB Solid Biosciences Inc.
3.1800
-4.22%
OCUL Ocular Therapeutix, Inc.
7.70
-1.03%
INZY Inozyme Pharma, Inc.
1.4400
-1.37%
LRMR Larimar Therapeutics, Inc.
3.8400
-3.27%
ZNTL Zentalis Pharmaceuticals, Inc.
1.7400
+4.82%
IKT Inhibikase Therapeutics, Inc.
2.2700
+18.23%
JSPR Jasper Therapeutics, Inc.
6.06
-9.55%
IKNA Ikena Oncology, Inc.
1.4800
-0.67%